Placental transfer and tissue accumulation of dolutegravir in the ex vivo human cotyledon perfusion model

Abstract : OBJECTIVE: To determine the transplacental pharmacokinetics of the HIV integrase inhibitor dolutegravir. STUDY DESIGN: Maternal-to-fetal transfer across the term human placenta was investigated with the ex-vivo dually perfused cotyledon model, in 5 closed-circuit, recirculating experiments. Dolutegravir was added to a maternal perfusate containing antipyrine, a marker to validate the cotyledon's viability, and 2 g/liter of human albumin. RESULTS: After 3h of recirculating perfusion, the mean (± SD) DTG concentrations in the maternal and in the fetal compartments were respectively 2450 ± 286 ng/mL and 715 ± 369 ng/mL, with a fetal-to-maternal ratio of 34% ± 18% and a clearance index (in comparison with antipyrine transfer) of 79% ± 23%. The mean cotyledon accumulation index was 153% ± 25%. CONCLUSION: Fetal transplacental exposure to dolutegravir was considerable as well as accumulation in placental tissue. Whether this may lead to risks for the exposed fetus requires more investigation.
Complete list of metadatas

Cited literature [39 references]  Display  Hide  Download

https://www.hal.inserm.fr/inserm-02272841
Contributor : Myriam Bodescot <>
Submitted on : Wednesday, August 28, 2019 - 11:17:21 AM
Last modification on : Friday, October 25, 2019 - 4:54:01 PM

File

journal.pone.0220323.pdf
Publication funded by an institution

Identifiers

Citation

Laurent Mandelbrot, Pierre-François Ceccaldi, Dominique Duro, Minh Lé, Lucile Pencolé, et al.. Placental transfer and tissue accumulation of dolutegravir in the ex vivo human cotyledon perfusion model. PLoS ONE, Public Library of Science, 2019, 14 (8), pp.e0220323. ⟨10.1371/journal.pone.0220323⟩. ⟨inserm-02272841⟩

Share

Metrics

Record views

49

Files downloads

55